Transaction Details

Footnotes

The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan, which was adopted on October 24, 2024. | Includes 1.5127 shares acquired under a dividend reinvestment plan. | This transaction was executed in multiple trades at prices ranging from $335.71 to $336.70. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. | his transaction was executed in multiple trades at prices ranging from $336.74 to $337.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. | This transaction was executed in multiple trades at prices ranging from $337.78 to $338.60. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. | This transaction was executed in multiple trades at prices ranging from $338.78 to $339.77. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. | This transaction was executed in multiple trades at prices ranging from $339.78 to $340.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. | This transaction was executed in multiple trades at prices ranging from $341.48 to $341.58. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. | This information is based on a plan statement dated September 30, 2025. | Option fully vested. | Exercise of Rule 16b-3 stock option pursuant to a Rule 10b5-1 Plan, which was adopted on October 24, 2024. | Original stock option grant vests in three annual installments beginning on the date listed in the "Date Exercisable" column. | 1 for 1. | The restricted stock units vest three years from the grant date on the date listed above, assuming continued employment. | If the Company achieves certain goals over the 2023-2025 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits. | If the Company achieves certain goals over the 2024-2026 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits. | If the Company achieves certain goals over the 2025-2027 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits. | Payment will be made in accordance with the reporting person's deferral election, death, disability or termination of employment.